Abstract:1 Recent work in our laboratory has demonstrated that intrathecal administration of a selective antagonist of calcitonin gene-related peptide (CGRP), CGRP(8-37), increased the hindpaw withdrawal latency (HWL) to thermal stimulation and hindpaw withdrawal threshold (HWT) to pressure in normal rats, and that these effects were more pronounced than in rats with mononeuropathy. 2 The present study was performed to investigate the effects of intrathecal administration of CGRP(8-37) on the HWL and HWT in rats with unilateral hindpaw inflammation induced by subcutaneous injection of carrageenin. The effect of naloxone was also studied. 3 Subcutaneous injection of 0.1 ml of carrageenin into the plantar region of the left hindpaw induced a significant increase in the volume of the ipsilateral hindpaw (P< 0.001), and significant bilateral decreases of the HWL to thermal stimulation (ipsilateral: P<0.001; contralateral: P<0.01) and HWT to pressure (ipsilateral: P<0.001; contralateral: P<0.01). 4 Intrathecal administration of 10 nmol of CGRP(8-37), but not of 1 or 5 nmol, induced a significant bilateral increase in the HWL and HWT in rats with experimentally induced inflammation (thermal test: P<0.001; mechanical test: P<0.001). 5 The effect of intrathecal administration of 10 nmol CGRPB(8-37) on HWL and HWT was significantly more pronounced in intact rats than in rats with experimentally induced inflammation (ipsilateral: P<0.001; contralateral: P<0.001). 6 The effect of CGRP(8-37) on withdrawal responses in the inflamed paw was partly reversed by intrathecal injection of naloxone at a dose of 88 nmol in the thermal (ipsilateral: P<0.01; contralateral: P=0.14) and mechanical tests (ipsilateral: P<0.05; contralateral: P=0.60). 7 A significant bilateral increase in the concentration of CGRP-like immunoreactivity in the perfusate of both hindpaws was demonstrated 24 h after unilateral injection of carrageenin (ipsilateral: P<0.001; contralateral: P<0.05). There was also an increase in the amount of CGRP-like immunoreactivity in the cerebrospinal fluid (P<0.001), but not in plasma (P=0.75). 8 The present study demonstrates that acute experimentally-induced unilateral hindpaw inflammation, induces bilateral increases in the amount of CGRP-like immunoreactivity in hindpaw perfusates. Intrathecal administration of CGRP(8-37) increased the HWL to thermal stimulation and HWT to pressure bilaterally. 9 The results indicate that CGRP plays a role in the transmission of presumed nociceptive information in the spinal cord of rats with experimentally induced inflammation. Furthermore, our findings suggest that opioids can modulate CGRP-related effects in the spinal cord.

Intrathecal CGRP8–37 results in a bilateral increase in hindpaw withdrawal latency in rats with a unilateral thermal injury

Intrathecal CGRP(8-37)-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation

Opioids Modulate the Calcitonin Gene-Related Peptide8–37 - Mediated Hindpaw Withdrawal Latency Increase in Thermally Injured Rats

The calcitonin gene-related peptide antagonist CGRP8–37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone

[Effects of Intrathecal Transient Receptor Potential Vanilloid 1 Blocker on Cervical Distension Induced Visceral Pain Response].

Opioid Antagonists Naloxone, Β-Funaltrexamine and Naltrindole, but Not Nor-Binaltorphimine, Reverse the Increased Hindpaw Withdrawal Latency in Rats Induced by Intrathecal Administration of the Calcitonin Gene-Related Peptide Antagonist CGRP8–37

Effects of Calcitonin Gene-Related Peptide-(8-37) on Withdrawal Responses in Rats with Inflammation

Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats.

Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats.

Antinociceptive Effects of Calcitonin Gene-Related Peptide Injected into Periaqueductal Grey of Rats with Mononeuropathy

Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.

Involvement of opioid receptors in the CGRP8-37-induced inhibition of the activity of wide-dynamic-range neurons in the spinal dorsal horn of rats.

Calcitonin gene-related peptide 8-37 inhibits the evoked discharge frequency of wide dynamic range neurons in dorsal horn of the spinal cord in rats

Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats.

Effects of intrathecal galanin on nociceptive responses in rats with mononeuropathy

Involvement of Opioid Receptors in the CGRP-induced Antinociception in the Nucleus Accumbens of Rats

Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice

Role of calcitonin gene-related peptide in pain regulation in the parabrachial nucleus of naive rats and rats with neuropathic pain

Effect of Pre-Emptive Intrathecal Administration of L-NAME on CGRP Expression in Spinal Dorsal Horn in a Rat Model of Neuropathic Pain

An Interaction of Opioids and Galanin in Dorsal Horn of the Spinal Cord in Mononeuropathic Rats

Plastic changes of calcitonin gene-related peptide in morphine tolerance: behavioral and immunohistochemical study in rats.